Why did PHRX.CN stock drop 33.33% today?

The drop reflects thin liquidity, below-average volume, and likely order imbalance rather than a single disclosure. Low market cap and negative EPS amplify price moves in CNQ trading for PHRX.CN stock.

What is the Meyka AI forecast for PHRX.CN stock?

Meyka AI's forecast model projects a monthly price of C$0.01 for PHRX.CN stock, equal to the current price and implying 0.00% near-term change. Forecasts are model-based projections and not guarantees.

What are key risks for PHRX.CN stock investors?

Key risks include low liquidity, tiny market cap (C$1,082,344.00), negative EPS, adverse trial or regulatory news, and volatile intraday swings—factors that make PHRX.CN stock high risk for larger positions.

Are there actionable price targets for PHRX.CN stock?

Scenario targets: downside C$0.005 (-50.00%), base C$0.01 (0.00%), recovery C$0.02 (+100.00%), and year high C$0.025 (+150.00%). Use these as framework, not guarantees.

CA Stocks

PHRX.CN Pharmadrug Inc. (CNQ) -33.33% Feb 14 market hours: what to watch

ByHuzaifa Zahoor February 14, 2026February 14, 2026

PHRX.CN stock dropped 33.33% to C$0.01 in market hours on Feb 14 2026, marking one of today’s top losers on the CNQ (Canada) board. Volume of 28,921 shares ran below the 50-day average of 37,944, suggesting a quick downside move rather than broad buying. Investors should note the stock’s low float and tiny market cap of C$1,082,344.00, plus near-term catalysts such as the next earnings announcement on 2026-05-21, when volatility could increase.